News

3.20.2015

Study Demonstrates New Noninvasive Gene Expression Profile Test Predicts Melanoma Risk More Accurately Than AJCC Online Predictor Tool

SAN FRANCISCO, CA – March 20, 2015 – Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment, today announced study results... READ MORE

3.18.2015

Survey of Thoracic Surgeons Reveals Willingness to Change Treatment Approaches to Esophageal Cancer Based on Castle Biosciences’ New Predictive Test

Friendswood, TX – March 18, 2015 – Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment, today announced the publication of... READ MORE